Patricia González-Berdullas

Dr. Patricia González-Berdullas

Chemistry Research Unit (CIQUP), Faculty of Sciences of University of Porto (FCUP), Porto, Portugal
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
Carla Marisa Pacheco MagalhãesCarla Marisa Pacheco Magalhães
Carla Marisa Pacheco Magalhães
Patricia González-BerdullasPatricia González-Berdullas
Patricia González-Berdullas
Diana Sousa DuarteDiana Sousa Duarte
Diana Sousa Duarte
ACAna Salomé Correia
Ana Salomé Correia
JRJosé E. Rodríguez-Borges
José E. Rodríguez-Borges
Luís Pinto da SilvaLuís Pinto da Silva
Luís Pinto da Silva
Photodynamic therapy (PDT) is an anticancer therapeutic modality with remarkable advantages over more conventional approaches. However, PDT is greatly limited by its dependence on external light sources. Given this, PDT would benefit from new systems capable of a light-free and intracellular photodynamic effect. Herein, we evaluated the heavy-atom effect as a strategy to provide anticancer activity to derivatives of coelenterazine, a chemiluminescent single-molecule widespread in marine organisms. Our results indicate that the use of the heavy-atom effect allows these molecules to generate readily available triplet states in a chemiluminescent reaction triggered by a cancer marker. Cytotoxicity assays in different cancer cell lines showed a heavy-atom-dependent anticancer activity, which increased in the substituent order of hydroxyl < chlorine < bromine. Furthermore, it was found that the magnitude of this anticancer activity is also dependent on the tumor type, being more relevant toward breast and prostate cancer. The compounds also showed moderate activity toward neuroblastoma, while showing limited activity toward colon cancer. In conclusion, the present results indicate that the application of the heavy-atom effect to marine coelenterazine could be a promising approach for the future development of new and optimized self-activating and tumor-selective sensitizers for light-free PDT.

Verified
Journal Article
Open access
PDF file
Patricia González-BerdullasPatricia González-Berdullas
Patricia González-Berdullas
Renato PereiraRenato Pereira
Renato Pereira
CTCláudia Sofia Machado Teixeira
Cláudia Sofia Machado Teixeira
JSJosé Pedro Silva
José Pedro Silva
Carla Marisa Pacheco MagalhãesCarla Marisa Pacheco Magalhães
Carla Marisa Pacheco Magalhães
Luís Pinto da SilvaLuís Pinto da Silva
Luís Pinto da Silva
Cancer is still a challenging disease to treat, both in terms of harmful side effects and therapeutic efficiency of the available treatments. Herein, to develop new therapeutic molecules, we have investigated the anticancer activity of halogenated derivatives of different components of the bioluminescent system of marine Coelenterazine: Coelenterazine (Clz) itself, Coelenteramide (Clmd), and Coelenteramine (Clm). We have found that Clz derivatives possess variable anticancer activity toward gastric and lung cancer. Interestingly, we also found that both brominated Clmd (Br-Clmd) and Clm (Br-Clm) were the most potent anticancer compounds toward these cell lines, with this being the first report of the anticancer potential of these types of molecules. Interestingly, Br-Clm possessed some safety profile towards noncancer cells. Further evaluation revealed that the latter compound induced cell death via apoptosis, with evidence for crosstalk between intrinsic and extrinsic pathways. Finally, a thorough exploration of the chemical space of the studied Br-Clm helped identify the structural features responsible for its observed anticancer activity. In conclusion, a new type of compounds with anticancer activity toward gastric and lung cancer was reported and characterized, which showed interesting properties to be considered as a starting point for future optimizations towards obtaining suitable chemotherapeutic agents.

5 May 2022 in Chemosensors
Verified
Journal Article
Open access
PDF file
JSJosé Pedro Silva
José Pedro Silva
Patricia González-BerdullasPatricia González-Berdullas
Patricia González-Berdullas
Joaquim C.G. Esteves Da SilvaJoaquim C.G. Esteves Da Silva
Joaquim C.G. Esteves Da Silva
Luís Pinto da SilvaLuís Pinto da Silva
Luís Pinto da Silva
Superoxide anion is a reactive oxygen species (ROS) of biological interest. More specifically, it plays a role in intra- and intercellular signaling, besides being associated with conditions such as inflammation and cancer. Given this, efforts have been made by the research community to devise new sensing strategies for this ROS species. Among them, the chemiluminescent reaction of marine Coelenterazine has been employed as a sensitive and dynamic probing approach. Nevertheless, chemiluminescent reactions are typically associated with lower emissions in aqueous solutions. Herein, here we report the synthesis of a new Coelenterazine derivative with the potential for superoxide anion sensing. Namely, this novel compound is capable of chemiluminescence in a dose-dependent manner when triggered by this ROS species. More importantly, the light-emission intensities provided by this derivative were relevantly enhanced (intensities 2.13 × 101 to 1.11 × 104 times higher) in aqueous solutions at different pH conditions when compared to native Coelenterazine. The half-life of the chemiluminescent signal is also greatly increased for the derivative. Thus, a new chemiluminescence molecule with significant potential for superoxide anion sensing was discovered and reported for the first time.

7 September 2021 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
Carla Marisa Pacheco MagalhãesCarla Marisa Pacheco Magalhães
Carla Marisa Pacheco Magalhães
Patricia González-BerdullasPatricia González-Berdullas
Patricia González-Berdullas
Joaquim C.G. Esteves Da SilvaJoaquim C.G. Esteves Da Silva
Joaquim C.G. Esteves Da Silva
Luís Pinto da SilvaLuís Pinto da Silva
Luís Pinto da Silva
Replacing the peroxide bond of dioxetanone prevents chemiluminescence by making its thermolysis energetically unfavorable and without a singlet chemiexcitation pathway.

Verified
Journal Article
Open access
PDF file
João SousaJoão Sousa
João Sousa
Carla Marisa Pacheco MagalhãesCarla Marisa Pacheco Magalhães
Carla Marisa Pacheco Magalhães
Patricia González-BerdullasPatricia González-Berdullas
Patricia González-Berdullas
Joaquim C.G. Esteves Da SilvaJoaquim C.G. Esteves Da Silva
Joaquim C.G. Esteves Da Silva
Luís Pinto da SilvaLuís Pinto da Silva
Luís Pinto da Silva
Chemi- and bioluminescence are remarkable light-emitting phenomena, in which thermal energy is converted into excitation energy due to a (bio)chemical reaction. Among a wide variety of chemi-/bioluminescent systems, one of the most well-known and studied systems is that of marine imidazopyrazinones, such as Coelenterazine and Cypridina luciferin. Due to the increasing usefulness of their chemi-/bioluminescent reactions in terms of imaging and sensing applications, among others, significant effort has been made over the years by researchers to develop new derivatives with enhanced properties. Herein, we report the synthesis and chemiluminescent characterization of a novel dibrominated Coelenterazine analog. This novel compound consistently showed superior luminescence, in terms of total light output and emission lifetime, to natural imidazopyrazinones and commercially available analogs in aprotic media, while being capable of yellow light emission. Finally, this new compound showed enhanced chemiluminescence in an aqueous solution when triggered by superoxide anion, showing potential to be used as a basis for optimized probes for reactive oxygen species. In conclusion, bromination of the imidazopyrazinone scaffold appears to be a suitable strategy for obtaining Coelenterazines with enhanced properties.

29 May 2023 in Applied Sciences
Verified
Journal Article
Open access
PDF file
El Hadi ErbiaiEl Hadi Erbiai
El Hadi Erbiai
Patricia González-BerdullasPatricia González-Berdullas
Patricia González-Berdullas
Joaquim C.G. Esteves Da SilvaJoaquim C.G. Esteves Da Silva
Joaquim C.G. Esteves Da Silva
Luís Pinto da SilvaLuís Pinto da Silva
Luís Pinto da Silva
Reactive oxygen species (ROS), including superoxide anion, are involved in regulating various signaling pathways and are also responsible for oxidative stress. Sensing superoxide anion is of particular importance due to its biological significance. One potential approach is to use Coelenterazine as a chemiluminescent probe for the dynamic sensing of this ROS. In this study, we investigated the superoxide anion-triggered chemiluminescence of native Coelenterazine and two halogenated analogs and found that they showed a ~100-fold enhancement of light emission in aqueous solution, which was significantly reduced in methanol and nonexistent in aprotic solvents. In fact, Coelenterazine showed more intense light emission in aprotic solvents and, interestingly, although the light emission of the analogs seemed relatively unaffected by the solvents, their chemiluminescence was significantly quenched in water compared to methanol and, especially, to aprotic media. This suggests that the quenching effect observed for Coelenterazine is responsible for the differences in aqueous media, rather than an intrinsic enhanced emission by the analogs. In summary, we present Coelenterazine analogs that could serve as a basis for enhanced sensing of superoxide anion, providing information that could further our understanding of this chemiluminescent system.